ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2096

Gamification and Social Incentivization to Promote Physical Activity in Adults with Knee Osteoarthritis: Results from a Multi-Site Randomized Trial

Kimberly Hayes1, Bryant England2, Katherine Wysham3, Mercedes Quinones4, Marianna Olave5, Sarah Wetzel6, Hannah Brubeck7, Rachel Gillcrist8, Criswell Lavery9, Natalie Keller10, Bibiana Ateh11, Bridget Kramer2, Rui Xiao9, Kaitian Jin9, Alexis Ogdie12, Daniel K. White13, Tuhina Neogi14, Carla Scanzello9 and Joshua Baker9, 1Teachers College, Columbia University, Philadelphia, PA, 2University of Nebraska Medical Center, Omaha, NE, 3VA PUGET SOUND/UNIVERSITY OF WASHINGTON, Seattle, WA, 4Washington DC VA Medical Center, Bethesda, MD, 5Brown University, Philadelphia, PA, 6Drexel University, Pittsburgh, PA, 7VA Puget Sound Health Care System, Seattle, WA, 8Dartmouth College, Lebanon, NH, 9University of Pennsylvania, Philadelphia, PA, 10University of Oklahoma, Philadelphia, PA, 11Washington VA Medical Center, Washington, District of Columbia, 12Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Wilmington, DE, 13University of Delaware, Newark, DE, 14Boston University School of Medicine, Boston, MA

Meeting: ACR Convergence 2025

Keywords: corticosteroids, Disease Activity, Osteoarthritis, pain, physical activity

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (2079–2105) Osteoarthritis – Clinical Poster II

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Promotion of physical activity is important in the management of knee osteoarthritis (KOA), though effective strategies for behavioral change to promote exercise are lacking. The aim of the study was to determine if an incentive program based on principles from behavioral economics including gamification and social incentivization could promote physical activity and reduce self-reported pain and disability in adults with KOA.

Methods: This was a factorially-designed multi-site randomized controlled clinical trial. Participants were randomized to receive an incentive program to promote greater physical activity or an attention control. Participants received a Fitbit monitor and completed patient-reported outcomes through a web-based platform. Participants who were randomized into the incentive program received points for achieving step goals and advanced in a game on a weekly basis based on their success. The control arm received a Fitbit and answered surveys but did not receive an incentive. Participants were also randomized to receive blinded corticosteroid injections v. lidocaine only in a factorial design. The analysis used mixed-effects models to evaluate the time-averaged effect of the intervention over a 28-week study follow-up on both average daily step counts (averaged over 2 weeks) as well as secondary patient-reported outcomes, including the Knee Osteoarthritis Outcome Score (KOOS). Secondary outcomes also included the Patient-Reported Outcomes Measurement Information System (PROMIS) pain assessments.

Results: Of 231 that were enrolled, 221 were randomized with an average age of 64 years and 84% male. Those that were randomized to the incentive (N&#3f110) walked an average of 830 (95% CI: 254, 1405) more steps/day than the control arm (N&#3f111) (p=0.005). The increase in steps/day compared to the control arm was similar across the 28-week study (Figure 1), though step counts generally declined with time in both groups. There were no significant differences in the effect of the intervention on the change in step counts by gender, Kelgren-Lawrence grade, baseline step count, or receipt of corticosteroid (v. lidocaine only) (Figure 2). While the incentive program resulted in an improvement in average daily step counts, there was no difference in the change in KOOS scores over the study period in the incentive group compared to the control group [β: -1.59 (95% CI: -4.51, 1.33) p=0.29] (Figure 3). The incentive group also did not report significant differences in change in pain intensity, pain behavior, or pain interference.

Conclusion: An incentive program designed with elements of gamification and social incentivization resulted in a significant increase in average daily steps compared to a control arm in participants with KOA. This difference equates to about a 10–15-minute walk or ½ mile a day and is considered meaningful. While there was improvement in activity, this study does not support prior evidence suggesting that an increase in walking will result in an improvement in symptoms. However, longer duration of sustained increased activity may be needed for symptomatic benefits. Notably the greater activity in the incentive arm did not result in worsening of symptoms.

Supporting image 1Figure 1: Change in average weekly step count changes in incentive (black triangles) and control groups (grey circles). Brackets indicate 95% confidence interval.

Supporting image 2Figure 2: Effect of the intervention (difference between incentive and control by subgroup). Brackets indicate 95% confidence interval.

Supporting image 3Figure 3: Change in the total KOOS score over 28 weeks among the incentive (black triangles) and control (grey circles) groups. Brackets indicate 95% confidence intervals.


Disclosures: K. Hayes: None; B. England: Boehringer-Ingelheim, 2, 5; K. Wysham: None; M. Quinones: None; M. Olave: None; S. Wetzel: None; H. Brubeck: None; R. Gillcrist: None; C. Lavery: None; N. Keller: None; B. Ateh: None; B. Kramer: None; R. Xiao: None; K. Jin: None; A. Ogdie: AbbVie, 5, Amgen, 5, 11, Bristol Myers Squibb, 5, Celgene, 5, CorEvitas, 2, Eli Lilly, 5, Novartis, 5, 11, Pfizer, 5, 11; D. White: None; T. Neogi: None; C. Scanzello: COMPOSITIONS AND METHODS FOR TREATING OSTEOARTHRITIS USING A CD14 INHIBITOR, 10; J. Baker: Amgen, 5.

To cite this abstract in AMA style:

Hayes K, England B, Wysham K, Quinones M, Olave M, Wetzel S, Brubeck H, Gillcrist R, Lavery C, Keller N, Ateh B, Kramer B, Xiao R, Jin K, Ogdie A, White D, Neogi T, Scanzello C, Baker J. Gamification and Social Incentivization to Promote Physical Activity in Adults with Knee Osteoarthritis: Results from a Multi-Site Randomized Trial [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/gamification-and-social-incentivization-to-promote-physical-activity-in-adults-with-knee-osteoarthritis-results-from-a-multi-site-randomized-trial/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/gamification-and-social-incentivization-to-promote-physical-activity-in-adults-with-knee-osteoarthritis-results-from-a-multi-site-randomized-trial/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology